Y79 Retinoblastoma Cells (Y79)

Y79 cell line is a well-established and widely used cell line in cancer research, specifically in the study of retinoblastoma. Retinoblastoma is a rare childhood cancer that originates in the retina of the eye, and Y79 cells were derived from a malignant tumor of the eye in a young patient.

Y79 cells have been extensively characterized and studied, making them a valuable tool for researchers investigating the biology of retinoblastoma and potential treatment options. These cells exhibit key characteristics of retinoblastoma, including rapid proliferation, anchorage-independent growth, and the ability to form tumors in animal models.

Studying Y79 cells has provided important insights into the mechanisms of retinoblastoma development, including the role of specific genetic mutations and signaling pathways in driving tumor growth. Researchers use Y79 cells to explore new therapeutic approaches, such as targeted therapies and immunotherapies, to improve outcomes for patients with retinoblastoma.